Magnesium pills might sharpen your mind while treating depression
NCT ID NCT07521358
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether taking magnesium supplements alongside the antidepressant fluoxetine can improve cognitive function in adults with major depression. Forty participants took either fluoxetine plus magnesium or fluoxetine alone for six weeks. Researchers measured changes in thinking skills and a brain protein called BDNF. The goal is to see if magnesium offers an extra benefit for mental clarity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Magnesium (dietary supplement)
- What this could lead to
- If it works, adding magnesium to standard depression treatment could help improve thinking and memory in people with depression.
- What could go wrong
- This is a very small, completed trial with only 40 people. Results may not apply to everyone, and magnesium might not provide any extra benefit beyond fluoxetine alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Wahidin Sudirohusodo Hospital
Makassar, South Sulawesi, 90245, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can couples counseling lift depression in women?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Can tailored brain zaps beat standard therapy for depression?
- Can a new daily pill lift the fog of depression?
- Can a new pill outsmart depression? a trial puts KH607 to the test
- Depression's biological fingerprint: a quest for objective diagnosis and personalized treatment